A Global Perspective: PARP Inhibitors in the Treatment of Metastatic Breast Cancer

Get up to date with international insights on assessing and targeting BRCA1/2 and other DNA damage repair gene alterations in metastatic breast cancer with downloadable slides from a video roundtable plus an expert commentary.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca